Pharma companies in the UK are being invited to register their new medicines with both the MHRA and NICE at the same time, as part of a push to reduce regulatory review times by three to six months.

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

Among the highlights of UK Chancellor John Healey's first Budget was more than £1 billion in investment by Convatec, Vertex ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Switzerland's Ferring Pharma has reached an agreement to buy US women's health startup Gameto for up to $1.38 billion, ...

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms ...

The Novartis Pavillon in Park South of the Novartis Campus in Basel, Switzerland. Novartis's third-quarter results included a ...

Smart ring manufacturer Oura has launched a clinical trial to see if data collected from its wearable devices can help ...

While Anthropic has not disclosed the number of shares to be released, their price range, or a date for the listing, ...

Moderna and MSD have shared keenly anticipated results for their melanoma cancer vaccine, ahead of a presentation at ESMO ...